| 000 | 00916 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250513194452.0 | ||
| 264 | 0 | _c19991130 | |
| 008 | 199911s 0 0 eng d | ||
| 022 | _a0340-6245 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKitchen, S | |
| 245 | 0 | 0 |
_aAnti Xa monitoring during treatment with low molecular weight heparin or danaparoid: inter-assay variability. _h[electronic resource] |
| 260 |
_bThrombosis and haemostasis _cOct 1999 |
||
| 300 |
_a1289-93 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAntibodies _xblood |
| 650 | 0 | 4 | _aDrug Monitoring |
| 650 | 0 | 4 |
_aFactor Xa _ximmunology |
| 650 | 0 | 4 |
_aHeparin, Low-Molecular-Weight _ximmunology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aThrombosis _xblood |
| 700 | 1 | _aIampietro, R | |
| 700 | 1 | _aWoolley, A M | |
| 700 | 1 | _aPreston, F E | |
| 773 | 0 |
_tThrombosis and haemostasis _gvol. 82 _gno. 4 _gp. 1289-93 |
|
| 999 |
_c10501656 _d10501656 |
||